MEDICINAL FORM OF BIPHASE EFFECT EXHIBITING RELEASING FOR LIPOPHILIC PREPARATIONS AND A METHOD OF ITS PREPARING Russian patent published in 1998 - IPC

Abstract RU 2121344 C1

FIELD: medicine, pharmacy. SUBSTANCE: medicinal form is used by oral route and consists of two phases: phase of nonprolonged releasing and phase of prolonged releasing the components. Form has C12-C24-fatty acid and pharmaceutically active lipophilic substance. Phase of nonprolonged releasing has part of fatty acid and phase of prolonged releasing has the rest part of fatty acid and at least part of pharmaceutically active substance. Mass ratio of fatty acid and an active substance is from 10:1 to 1:1. C12-C24-fatty acid is an oleic and/or linolenic acid. Pharmaceutically active lipophilic substance is a propranolol, verapamil, nifedipin, diltiazem, methoprolol, nicardipine and/or labetolol. New medicinal form promotes an absorption redistribution of drug from portal circulatory system to lymphatic system and excludes drug metabolism at its the first passing through the liver. Drug bioavailability is enhanced. EFFECT: enhanced effectiveness of medicinal form. 13 cl, 2 ex

Similar patents RU2121344C1

Title Year Author Number
PHARMACEUTICAL COMPOSITION AS AN MICROEMULSION WITH BIOLOGICALLY ACTIVE MACROMOLECULAR MATERIAL AND A METHOD OF ITS PREPARING 1989
  • Jang V.Cho
  • Majkl Dzh.Flinn
RU2122403C1
PHARMACEUTICAL DELIVERY SYSTEMS FOR HYDROPHOBIC THERAPEUTIC AGENTS AND COMPOSITIONS CONTAINING IT 2006
  • Dadli Robert I.
  • Konstantinides Panajotis P.
RU2429850C2
PHARMACEUTICAL DELIVERY SYSTEMS FOR HYDROPHOBIC MEDICINAL PRODUCTS AND COMPOSITIONS CONTAINING THEM 2006
  • Dadli Robert I.
  • Konstantinides Panajotis P.
RU2623206C2
PHARMACEUTICAL COMPOSITION, METHOD OF ITS PREPARING AND METHOD OF INCREASE OF AN ACTIVE SUBSTANCE BIOLOGICAL AVAILABILITY USING THIS COMPOSITION 1991
  • Jang V.Cho[Us]
  • Majkl Dzhon Flin[Gb]
  • Tomas Smit Shehferd[Gb]
RU2104715C1
PHARMACEUTICAL COMPOSITION COMPRISING CYCLOSPORINE AS ACTIVE COMPONENT 2000
  • Singkh Amardzhit
  • Dzhejn Radzhesh
RU2207870C2
ORAL PHARMACEUTICAL COMPOSITIONS OF TESTOSTERONE ESTERS AND METHOD FOR TESTOSTERONE SHORTAGE TREATMENT WITH THEIR USE 2010
  • Dudlej Robert E.
  • Konstantinides Panajotis P.
RU2642244C2
PHARMACEUTICAL COMPOSITION EXHIBITING CARDIOVASCULAR EFFECT 1999
  • Zuev A.P.
  • Tjuljaev I.I.
  • Jurchenko N.I.
  • Bykov V.A.
  • Demchenko B.I.
RU2145214C1
SOLID PER ORAL MEDICATION, CONTAINING INTENSIFIER 2007
  • Leonard Tomas U.
RU2437662C2
DOSAGE FORMS CONTAINING DOPAMINE AGONISTS FOR PARENTERAL ADMINISTRATION 2009
  • Sinkotta Ehntoni Kh.
RU2532347C2
DOSAGE FORM AND USE OF DIETHYLSTILBESTROL FOR TREATING PROSTATE CANCER OR BREAST CANCER 2012
  • Chou Diana Shu-Lian
  • Ako Roland A.
  • Rioo Dze Pkhil
  • Chu Chun Kvong
  • Van Chzhen
RU2602296C2

RU 2 121 344 C1

Authors

Stiven Dzhordzh Barnvell

Dates

1998-11-10Published

1991-10-18Filed